|
Early use of
non-invasive ventilation reduces mortality and further ventilatory interventions
|
In COPD patients, with acute exacerbations associated with
mild - moderate respiratory acidosis NIV on the respiratory ward reduces
mortality (NNT 10) and the need for intubation (NNT 8).
Level of Evidence:
1+(well conducted RCT with a low risk of Bias) |
Citation/s: Plant
PK. Owen JL. Elliott MW. Early use of non-invasive ventilation for acute
exacerbations of chronic obstructive pulmonary disease on general respiratory
wards: a multicentre randomised controlled trial. Lancet. 2000
355(9219):1931-5.
Lead author's name and fax: Plant PK St James University Hospital, Leeds.
Three-part Clinical Question: In patients with
acute exacerbations of COPD, does non-invasive ventilation on a general ward
improve mortality?
Search Terms: non-invasive ventilation AND Exacerbation COPD. RCTs
The Study: Non-blinded concealed randomised
controlled trial with intention-to-treat.
The Study Patients: Acute exacerbation of COPD (respiratory rate>23, pH
7.25 -7.35 and PCO2 >6kPa) and GCS >/= 8/15. Absence of pneumothorax. Within 12
hours of admission.
Control group (N = 118; 118 analysed): Controlled oxygen to maintain SpO2
85-90%, nebulised salbutamol 5mg 4hourly, nebulised ipratopium 500microgram
6hourly, prednisolone 30mg daily for at least 5 days and an antibiotic.
Aminophylline and doxapram permitted.
Experimental group (N = 118; 118 analysed): Same medications as control
group plus.... Bilevel assist mode ventilator - Expiratory pressure set at
4cmH2O and inspiratory pressure set at 10cmH2O and increased by 5cmH2o to
20cmH2O or maximum tolerated for 1 hour. Oxygen entrained to keep SpO2 85 - 90%.
Duration = as much as possible on day 1, 16hours on day 2, 12 hours on day 3 and
discontinued on day 4
The Evidence:
|
Outcome |
Time to Outcome |
CER |
EER |
RRR |
ARR |
NNT |
|
Mortality |
in hospital |
0.203 |
0.102 |
50% |
0.101 |
10 |
|
95% Confidence Intervals: |
5% to 94% |
0.010 to 0.192 |
5 to 98 |
|
Need for intubation |
In hoppital |
0.271 |
0.153 |
44% |
0.118 |
8 |
|
95% Confidence Intervals: |
5% to 82% |
0.015 to 0.221 |
5 to 68 |
EBM Comments:
1) Do the methods allow accurate testing of the
hypothesis? Yes
2) Do the statistical tests correctly test the results to allow differentiation
of statistically significant results? Yes
3) Are conclusions valid in light of the results? Yes
4) Did results get omitted, and why? No
5) Did they suggest areas of further research? No
6) Did they make any recommendations based on the results and were they
appropriate? That NIV was feasible and effective in the respiratory ward setting
but there must be rapid access to invasive ventilation for those patients who
fail NIV.
7) Is the study relevant to my clinical practice? Yes – Although this
study was based on ward patients many hospitals do not offer non-invasive
ventilation outside of the intensive unit. Much of the work load of these units
could be avoided by expanding the use of non-invasive ventilation and its early
application to patients with COPD exacerbations having pH 7.25 - 7.35.
For every 10 patients receiving NIV one life will be saved and for every 8 an
intubation will be avoided. This is somewhat less than in the Brochard (NEJM
1995) paper but still very significant.
8) What level of evidence does
this study represent? Level 1+
9) What grade of recommendation
can I make on this result alone? Grade B
10) What
grade of recommendation can
I make when this study is considered along with other available evidence?
Grade A
11) Should I change my practice because of these results? Depends upon what you
are doing now.Interestingly the intervention only added an extra 26mins of
nursing time to the first 8 hours of admission and no difference after that. The
length of hospital stay did not alter between the two groups.
There was a high degree of acceptance of NIV by the patients - established (i.e.
> 1 hour usage) in 93% and a median time of 8 hours usage in the first 24 hours.
12) Should I audit my current practice because of these results? Yes –
all Intubated patients due to exacerbation of COPD should be audited as to their
‘pre’ ICU care.
Appraised by: Ewan Jack University department of
anaesthesia Glasgow Royal Infirmary 0141 211 4625; 15 November 2004
Email:
ewanwendy@supanet.com
Edited by CC & SJM
Kill or Update By: Dec 2010
Citation:
EBM Critical Appraisals. Scottish Intensive Care Society EBM Group. Jack E.
2005. : Plant
PK. Owen JL. Elliott MW.
Early use of non-invasive ventilation for acute exacerbations of chronic
obstructive pulmonary disease on general respiratory wards: a multicentre
randomised controlled trial. Lancet. 2000 355(9219):1931-5.
Printer friendly view
©SICS EBM 2005
|